Liver transplantation for advanced hepatocellular carcinoma in patients with Child-Pugh A and B
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 2011;29:339–64.
Japan Society of Hepatology. Clinical practice guidelines for hepatocellular carcinoma (2013 version) (In Japanese). Tokyo: Kanehara; 2013.
Takahashi S, Kudo M, Chung H, Inoue T, Nagashima M, Kitai S, et al. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation. Dig Dis. 2007;25:303–9.
Graf D, Vallböhmer D, Knoefel WT, Kröpil P, Antoch G, Sagir A, et al. Multimodal treatment of hepatocellular carcinoma. Eur J Intern Med. 2014;25:430–7.
Jiang L, Liao A, Wen T, Yan L, Li B, Yang J. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria. Transpl Int. 2014;27:562–9.
Sapisochin G, Castells L, Dopazo C, Bilbao I, Minguez B, Lázaro JL, et al. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol. 2013;20:1194–202.
Kaido T, Takada Y, Uemoto S. Usefulness of the Kyoto criteria as selection criteria for living donor liver transplantation for hepatocellular carcinoma. Liver Transpl. 2010;16:538–40.
Kaido T, Ogawa K, Mori A, Fujimoto Y, Ito T, Tomiyama K, et al. Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma. Surgery. 2013;154:1053–60.
Fujiki M, Takada Y, Ogura Y, Oike F, Kaido T, Teramukai S, et al. Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma. Am J Transplant. 2009;9:2362–71.
Takada Y, Ito T, Ueda M, Sakamoto S, Haga H, Maetani Y, et al. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl. 2006;12:912–9.
Morioka D, Egawa H, Kasahara M, Ito T, Haga H, Takada Y, et al. Outcomes of adult-to adult living donor liver transplantation: a single institution’s experience with 335 consecutive cases. Ann Surg. 2007;245:315–25.
Inomata Y, Uemoto S, Asonuma K, Egawa H. Right lobe graft in living donor liver transplantation. Transplantation. 2000;69:258–64.
Ito T, Kiuchi T, Egawa H, Kaihara S, Oike F, Ogura Y, et al. Surgery-related morbidity in living donors of right-lobe liver graft: lessons from the first 200 cases. Transplantation. 2003;76:158–63.
Inomata Y, Tanaka K, Egawa H, Uemoto S, Ozaki N, Okajima H, et al. The evolution of immunosuppression with FK 506 in pediatric living related liver transplantation. Transplantation. 1996;61:247–52.
Egawa H, Ohdan H, Haga H, Tsuruyama T, Oike F, Uemoto S, Ozawa K. Current status of liver transplantation across ABO blood-type barrier. J Hepatobiliary Pancreat Surg. 2008;15:131–8.
Hammad A, Kaido T, Uemoto S. Perioperative nutritional therapy in liver transplantation. Surg Today. 2015;45:271–83.
Ikegami T, Shirabe K, Yoshiya S, Soejima Y, Yoshizumi T, Uchiyama H, et al. One-step reconstruction of the right inferior hepatic veins using auto-venous grafts in living donor liver transplantation. Surg Today. 2013;43:769–76.
Wang B, He HK, Cheng B, Wei K, Min S. Effect of low central venous pressure on postoperative pulmonary complications in patients undergoing liver transplantation. Surg Today. 2013;43:777–81.
Poon RT. Liver transplantation for solitary hepatocellular carcinoma less than 3 cm in diameter in Child A cirrhosis. Dig Dis. 2007;25:334–40.
Taniguchi M, Shimamura T, Todo S, Furukawa H. Small-for-size syndrome in living-donor liver transplantation using a left lobe graft. Surg Today. 2014. doi: 10.1007/s00595-014-0945-x .
Vitale A, Boccagni P, Brolese A, Neri D, Srsen N, Zanus G, et al. Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation. Transplant Proc. 2009;41:1264–7.
Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation. 2007;83:893–9.
Moon DB, Lee SG, Hwang S. Liver transplantation for hepatocellular carcinoma: single nodule with Child-Pugh class A sized less than 3 cm. Dig Dis. 2007;25:320–8.
Hu RH, Ho MC, Wu YM, Yu SC, Lee PH. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma. Clin Transplant. 2005;19:175–80.